Cutenox G 300 Mg Injection

Product Description

Introduction to Cutenox-g 300mg Injection

Cutenox-G 300mg Injection is an anticoagulant drug belonging to the category of low molecular weight heparin (LMWH). It  contains the active ingredient Enoxaparin. It is used to treat severe blood clots. This drug also prevents the occurrence of deep vein thrombosis in abdominal surgery, hip replacement surgery, knee replacement surgery, and in people with severe movement restrictions. This injection prevents further heart complications in patients with unstable angina and non-Q wave myocardial infarction.

Cutenox-G 300mg Injection is not recommended for patients with active bleeding, hypersensitivity or allergic to the active compound, and a history of heparin-induced thrombocytopenia. Before taking Cutenox-G 300mg Injection, tell your physician if you are allergic to enoxaparin sodium, heparin, benzyl alcohol, or pork products. Your healthcare provider will regularly monitor you for signs of bleeding. Inform your healthcare practitioner if you are diagnosed with kidney problems. It is not recommended for use in children and adolescents below 18 years. It is not recommended to use Cutenox-G 300mg Injection if you undergo procedures like neuraxial anaesthesia or spinal puncture. It is recommended to monitor older adults and patients with low weight  for increased risk of bleeding.

Tell your physician if you suspect pregnancy, breastfeeding, or planning to have a baby. Cutenox-G 300mg Injection may increase the chance of bleeding in pregnant women and hence close monitoring must be done. Consult your doctor for more advice. Before starting enoxaparin sodium medication, it is recommended not to take any hemostatic drugs unless absolutely necessary.  It is necessary to inform your physician about all the drugs you are taking including herbal and vitamin supplements.

Efficient Thromboprophylaxis and Treatment

Cutenox G is designed to prevent and treat serious blood clotting conditions such as DVT and pulmonary embolism. Its primary benefit lies in reducing the risk of blood clots in patients undergoing surgery or those with acute illnesses, offering targeted anticoagulation with a predictable safety profile. The prefilled syringe allows for consistent dosing and ease of administration by healthcare professionals.


Administration and Handling Guidelines

Cutenox G Injection should be given only as a subcutaneous injection, typically in the abdomen or thigh, following strict aseptic precautions. Dosage is determined by your physician based on your specific health condition. Proper storage-below 25C and protected from light-is crucial to maintain the medication's efficacy. Never freeze the injection and always use before the expiration date.